We're in this fight together, and the Press is taking note.
The DEA’s proposed post-pandemic changes to telemedicine flexibilities in treating the opioid crisis has stirred intense backlash, prompting the agency to take a pause before implementing new rules. NBC’s Jesse Kirsch reports from Ohio.
When the COVID-19 public health emergency ends in May, some patients will face new hurdles to the telemedicine services they’ve relied on for three years.
The new telehealth restrictions proposed by the Drug Enforcement Administration (DEA) last week struck a sour chord with several industry stakeholders.